Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 47864Generated: October 30, 2026

3-Pyridinemethanamine → HCID 11006299, compound

https://huagongshe.com/reaction/47864

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-PyridinemethanamineHCID 31018—
ReactantDiisopropylethylamineHCID 81531—
ReactantPyBOPHCID 2724699—
ReactantHCID 11071570HCID 11071570—
SolventDimethylformamideHCID 6228—
SolventDichloromethaneHCID 6344—
SolventTrifluoroacetic acidHCID 6422—
ProductHCID 11006299HCID 11006299—

Reaction Steps

A solution of tert-butyl 4-[N-[7-chloro-3-methyl-4-oxo-2-piperidinomethyl-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]benzoate (Preparation Example 16) (0.086 g, 0.16 mmol) in dichloromethane (1.2 ml) and trifluoroacetic acid (1.6 ml) was stirred at room temperature for 55 min with protection from the light. The solvents were then removed in vacuo and the residue was treated with toluene/dichloromethane; concentrated in vacuo and the residue was dried in vacuo over P2O5. This solid was dissolved in anhydrous DMF (1.2 ml) under argon and the solution was placed in an ice-bath. A solution of 3-(aminomethyl)pyridine (0.026 g, 0.24 mmol) in DMF (0.2 ml) was then added followed by PyBOP® (0.087 g, 0.168 mmol) and diisopropylethylamine (0.123 g, 0.96 mmol). Stirring was continued at 0° C. for 3 min; then the ice-bath was removed and the reaction mixture was stirred for an additional 3 h at room temperature before being partitioned between ethyl acetate (200 ml) and saturated aqueous bicarbonate (100 ml). The organic layer was washed with more saturated aqueous bicarbonate (100 ml) and brine (100 ml), dried (Na2SO4) and concentrated in vacuo. The residue was purified by column chromatography using 3% methanol in dichloromethane as eluant, then triturated with 20% dichloromethane in hexanes to give a white solid which was collected by filtration, washed with hexanes and dried in vacuo over P2O5 (0.072 g, 79%), mp 148-150° C.; 1H-NMR (DMSO-d6) 1.48 (br s, 6H, piperidine CH2CH2CH2), 2.43 (br s, 4H, piperidine CH2NCH2), 3.18 (s, 1H, C≡CH), 3.61 (s, 3H, N3-Me), 3.57 (s, 2H, 2-CH2), 4.36 (s, 2H, CH2C≡C), 4.45 (d, J=5.7 Hz, 2H, CONHCH2), 4.77 (s, 2H, 6-CH2), 6.79 (d, J=8.8 Hz, 2H, 3,5′-ArH), 7.32 (dd, J=4.8, 7.8 Hz, 1H, pyr 5-H), 7.68 (d, J=7.7 Hz, 1H, pyr 4-H), 7.76 (d, J=8.7 Hz, 2H, 2′,6′-ArH), 7.79, 7.93 (2×s, 2H, 5-H, 8-H), 8.43 (d, J=3.6 Hz, 1H, pyr 6-H), 8.52 (s, 1H, pyr 2-H), 8.73 (t, J=5.9 Hz, 1H, CONH).; MS (FAB, m/z) 569,571 [(M+H)+, 100%, 40% respectively; Cl isotopic pattern]. FAB-HRMS: measured 569.2403; calculated for C32H34ClN6O2 (M+H)+: 569.2432.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06699861B1
Source datasetuspto-grants-2004_03
ORD IDord-0ea3186c81a440209f73bf6666b2e125
Source noteuspto-grants-2004_03